🚀 As we enter 2024, we can’t help but look with pride at Cardiawave’s incredible achievements in 2023 as we get closer and closer to launching our non-invasive ultrasound therapy device! 🎉
🏆Received 3 new patents in the United States.
💉 Completion of our “Valvosoft® Pivotal Study” with the treatment of 60 patients with severe calcific aortic stenosis with our experimental device.
🌟 Receiving the French Care Seal for our commitment to excellence in healthcare.
🏅 Winner of the French Tech Health 20 Prize, which rewards our commitment to pushing the boundaries of innovation in the field of cardiology.
📰 News articles and television reports highlight the changes our technology is bringing to the non-invasive treatment of patients with severe aortic stenosis.
📚 Publishing significant scientific articles that contribute to the advancement of knowledge in our field.
👥 Grateful for the support of our 5000+ LinkedIn followers! Thank you for being an integral part of our journey.
Thank you to patients, our partners, healthcare facilities and the entire Cardiawave team for all of these achievements.
We wish you a year of success, growth, and continued commitment to making a positive impact in healthcare! 🌐✨
#Innovation #AnnualReview #NewYear2024 #HealthTechInnovation #heartvalvedisease #FocusedUltrasound #Aortic stenosis #NIUT #FrenchCare #Health20
Let’s celebrate Cardiawave’s successes together in 2023! – Cardiawave
Related Posts
10 new members of the French Health Association in March
Find out who the ten companies are joining French Health Association in March 2024: Cahouet develops, produces and sells equipment for the use of pressurized medical gases. They have 80…
Epsidy, the cardiovascular health startup, has ISO certification
The young start-up with BPI’s Deeptech label has just received its ISO 13485 certification to continue its strong development and commercialization of very innovative medical devices for cardiac imaging. This…